الرئيس التنفيذي لشركة "سبيماكو الدوائية" السعودية لـ CNBC عربية: زيادة المبيعات وخفض النفقات من الأسباب التي أدت إلى تقليص الخسائر في 2023
Category
🗞
NewsTranscript
00:00 Jérôme Cabans, the president of the Saudi pharmaceutical company,
00:04 and the medical suppliers, Spemabco.
00:08 Welcome, Mr. Jérôme.
00:11 First, we congratulate you on becoming the president of this company.
00:16 Will this lead to changes in the strategy of this company?
00:22 Good morning, everyone.
00:28 Thanks for the good and thanks for the invitation.
00:31 We are here to highlight what Spemabco is doing and what it continues to do.
00:36 In response to your question, the strategy will remain unchanged,
00:41 focusing on the growth of innovation.
00:45 In addition, as a main engine, it will be working to speed up our goals,
00:52 in addition to working to continue to achieve efficiency and productivity improvement in the core of the company's work.
01:04 You have significantly reduced your losses between 2022 and 2023.
01:14 We understand the support of sales and the reduction of expenses.
01:19 Is this all? Give us more details.
01:22 As you noted, we were able to reduce losses due to the growth of sales and low expenses.
01:42 We are committed to managing our expenses and working to reduce them continuously.
01:50 We are working to reduce them from 47.9% to 37.4% as a percentage of revenues.
01:58 This is due to several reasons, including the growth of sales,
02:02 in addition to our reduction of expenses and working to focus on our approach
02:08 to managing our expenses and working to reduce our losses.
02:17 We also saw an increase of 3% annually in net profit,
02:24 which reflects the efficiency of the company and the success of our strategy to reduce expenses.
02:35 We will continue to do this.
02:37 By showing your performance in 2023, we find that you have achieved profits throughout the year.
02:44 What happened in the fourth quarter, when you lost 49 million riyals?
02:52 What happened is a continuation of what we call fixing the core.
03:06 We were working according to the plan, and in the fourth quarter of 2023,
03:13 we saw a reduction of 9%.
03:15 This has had a great impact on the work we do.
03:23 We have the will to carry out the additional drawings
03:31 and we have to work to reduce the costs of increasing the units of storage.
03:45 We recorded an increase of 80% annually in terms of our increase in new products.
03:53 Despite the negative impact on profits in the fourth quarter,
04:01 Spimaco was able to add 91 units of new storage.
04:09 We had to pay 21 million as a drawing value for previous years.
04:17 This has affected the results and the cost of financing has also increased
04:28 due to the increase in the cost of financing due to the increase in interest rates.
04:35 In addition to that, we had positive contributions from the company's work.
04:43 Without a doubt, the numbers in the fourth quarter may not have been better,
04:49 but we were not greatly affected and the future financial figures will be better.
04:56 What is your financial position?
05:00 In terms of financial support, what are your commitments?
05:04 What are your loans?
05:08 I think what we can say in terms of the question is definitely that the financial position
05:16 is strong and we are working to support our debt.
05:20 According to the main payments, we are in a clear process in the company
05:27 to correct the financial position.
05:30 The goal is to reduce the debt of the company
05:34 and to increase the profits after the discount,
05:38 benefits, taxes, consumption and payment of debts.
05:42 Mr. Jerome, you are in 16 countries.
05:46 What are the difficulties you face, especially in light of the changes you have learned,
05:52 geopolitical tensions, and the disruption of the supply chain,
05:56 inflation and currency fluctuation?
06:00 So, as per our vision, we seek a geographical expansion.
06:10 The vision we have for the company is to focus on four main areas
06:16 and work outside the Arab and Gulf regions.
06:20 We are trying to increase our activities outside this region
06:26 in more countries.
06:30 Ultimately, we know that we are affected by external circumstances.
06:36 We know that we have challenges in the future,
06:40 and reaching international markets remains a very important and essential goal for our company.
06:46 As for geopolitical tensions and their impact,
06:50 of course, these tensions have greatly affected our ambitions
06:54 and our work in the expansion of our geographical expansion.
06:58 However, we believe that through the new strategy for 2024,
07:06 we will build on the opportunities available in the multiple markets and we will achieve them.
07:12 The last point is the supply chain and its disruption.
07:16 Of course, we have learned during the COVID pandemic from the disruption of this supply chain.
07:22 We are trying to reduce the impact of this disruption,
07:26 and not to affect our achievements in terms of all the components of our medicines and factories.
07:34 We aim to serve all patients who are our priority.
07:42 Thank you, Jinum Kaban, CEO of the Saudi company for pharmaceuticals and medical supplies.
07:50 Thank you very much.
07:51 You were with us from Riyadh.
07:52 Thank you.